Exchange: NYSE·Updated 07:45 PM EST
A logo

A Agilent Technologies Inc.

$170.38
$4.96
(2.83%)
Today
Closed $170.38
$1.62
(0.95%)
After Hours
EarningsNov 23
Mkt Cap$48.04B
Vol1.88M

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
41

Bearish Sentiment

How do you feel about A?

KryptonResearch14
$A The longer-term book in the filing is pretty small, $434M of remaining performance obligations for contracts over a year at Jul 31, most of it expected in the next twelve months. Deferred revenue was $640M, up just $16M from Oct 31, 2025. The filing applies the practical expedient for contracts of a year or less, so that $434M is not total backlog.
KryptonResearch14
$A Segment income was $1,457M for the nine months, but $261M of unallocated costs sat below that line, up from $242M a year earlier. Transformational initiatives were $95M of it, against $48M, while restructuring fell to $43M from $74M and deal amortization to $59M from $81M.
KryptonResearch14
$A CrossLab was Agilent's biggest segment in Q3, $786M of revenue against $746M for Life Sciences and Diagnostics Markets, and it made more too, $270M of segment income against $176M. Nine months was the same shape, CrossLab $2,303M and $752M of segment income, LSDM $2,157M and $446M.
AdamBrennan2
$A management tone in q3 26 hit 25.4, up from 19.5 average the four quarters before guided up for the third straight quarter, now expecting 7.49 to 7.51 billion in fy26 revenue $TMO $WAT $IQV $ILMN
dustlesspuma
🟢 $A 175C Dec 18 💰 $156,000 premium 💵 $0/contract 📊 0x Vol/OI 📍 Spot $156 💰 Large premium 🌊 Dark Flow | Options Flow
optik
$A rmbr my prevision 112 to 150/160 ,today 186 , Ecolab 245 today 303. performer the market. only Camtek not go well, for the moment.
astuteoptics1
$A Agilent Technologies sits at $172.97 with a trailing GAAP P/E of 34.0x against a peer median of 40.8x, anchored by an ROE of 19.6% and an operating margin of 22.2%. Fundamentals are supported by a Q3 beat and raised fiscal 2026 EPS guidance of $6.18 to $6.21, alongside a net debt position of $2.2B against $1.6B of fiscal 2025 operating cash flow. Technically, the shares trade above the 20-day moving average of $170.55, the 50-day moving average of $158.89, and the 200-day moving average of $134.50. Sentiment is backed by short interest falling 8% month-over-month to 1.9% of float and 7 of the 10 largest institutional holders adding to their positions. What would change our mind: a break below the 200-day moving average or weaker China orders. (Disclosure: we're and this is our own research.)

Advertisement|Remove ads.